GE HealthCare Technologies Inc. (GEHC) — Capital Reinvestment Ratio

Latest as of March 2026: 0.61x

GE HealthCare Technologies Inc. (GEHC) has a Capital Reinvestment Ratio of 0.61x as of March 2026, meaning it reinvests 1% of its operating cash flow ($290.00 Million) in capital expenditures ($178.00 Million). Check tangible net worth ratio of GE HealthCare Technologies Inc. to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.61x
Capex / Operating Cash Flow

Operating Cash Flow

$290.00 Million
USD

Capital Expenditures

$178.00 Million
USD

Data as of

Mar 2026
Most recent filing

GE HealthCare Technologies Inc. Capital Reinvestment Ratio (2019–2025)

This chart tracks GE HealthCare Technologies Inc.'s Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see GEHC cash flow metrics.

Annual Capital Reinvestment Ratio for GE HealthCare Technologies Inc. (2019–2025)

Year-by-year Capital Reinvestment Ratio for GE HealthCare Technologies Inc. from 2019 to 2025. See cash generation quality of GE HealthCare Technologies Inc. to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.24x $1.99 Billion $482.00 Million ▲ +18.0%
2024 0.21x $1.95 Billion $401.00 Million ▲ +11.6%
2023 0.18x $2.10 Billion $387.00 Million ▲ +25.6%
2022 0.15x $2.11 Billion $310.00 Million ▼ -4.9%
2021 0.15x $1.61 Billion $248.00 Million ▲ +0.5%
2020 0.15x $1.69 Billion $259.00 Million ▼ -7.7%
2019 0.17x $1.99 Billion $331.00 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow